65 completed, 21 unknown, 15 recruiting, 8 active not recruiting. 25 Phase 2, 17 Not applicable, 14 Phase 1, 14 Phase 3, 7 Phase 4.
Follow Renal Tubular Transport, Inborn Errors: new trials by email Literature Review of Renal Tubular Transport, Inborn Errors trials Research Report on Renal Tubular Transport, Inborn Errors
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Accuracy of Home Lactate Meter and Accu-chek Glucometer in Patients With Glycogen Storage Disease Lactate Meter, Accu Chek - Glycogen Storage Disease Type IA, Glycogen Storage Disease Type I | Recruiting | Connecticut Children's Medical Center | 10 | 2026-09-18 | 2026-10-29 | |
| Morphology in Oral Rare Syndromes & Artificial Intelligence for Clinical Diagnosis intra-oral 3D optical impression - Osteogenesis Imperfecta, Rare Bone Disorders | Not applicable | Not yet recruiting | University Hospital, Bordeaux | 240 | 2026-09-01 | 2026-06-24 |
| Treatment Patterns, Biochemical Profiles and Clinical Outcomes in Adults With X-Linked Hypophosphatemia No treatment given - X-linked Hypophosphatemia (XLH) | Withdrawn | Novo Nordisk A/S | 2026-07-07 | 2026-08-28 | ||
| An Open-label, Phase 2 Pilot Study on the Efficacy and Safety of Piclidenoson in Patients With Lowe Syndrome Piclidenoson - Lowe Syndrome | Phase 2 | Not yet recruiting | Can-Fite BioPharma | 5 | 2026-06-01 | 2026-02-18 |
| Effective Dosing of Burosumab in XLH X-linked Hypophosphatemia (XLH) | Recruiting | University of Nottingham | 120 | 2025-11-03 | 2026-05-11 | |
| DFT383 in Pediatric Participants With Nephropathic Cystinosis DFT383 - Nephropathic Cystinosis | Phase 1 / Phase 2 | Recruiting | Novartis Pharmaceuticals | 30 | 2025-06-02 | 2026-10-16 |
| Phosphorus-31 Spectroscopy in Phosphate Diabetes intra-muscular ATP values in phosphate diabetes, intra-muscular phosphate values in phosphate diabetes - Phosphate Diabetes, X-linked Hypophosphatemia | Not applicable | Recruiting | Hospices Civils de Lyon | 65 | 2025-05-16 | 2026-07-23 |
| A Study Comparing the Necessity of a Second Transurethral Resection in High-Risk Non-Muscle-Invasive Bladder Cancer Patients With Negative Results From Post-Initial Resection Urine Genome-Wide Low-Depth Sequencing Urine biomarker -Guided without reTURBT - Non Muscle Invasive Bladder Cancer | Not applicable | Recruiting | The First Affiliated Hospital with Nanjing Medical University | 428 | 2025-02-01 | 2025-06-25 |
| A First-in-human Study of KK8123 in Adults With X-linked Hypophosphatemia KK8123 - X-linked Hypophosphatemia | Phase 1 / Phase 2 | Recruiting | Kyowa Kirin Co., Ltd. | 39 | 2024-10-09 | 2026-09-21 |
| Ultrasound for Socket Healing Evaluation Healing Wound, Alveolar; Wound | Active not recruiting | University of Michigan | 140 | 2024-07-25 | 2026-09-14 | |
| Study Evaluating Patients With Cystinuria ADV7103, Standard of Care - Cystinuria | Phase 2 / Phase 3 | Withdrawn | Advicenne Pharma | 2024-05-01 | 2024-03-12 | |
| Effect of Burosumab on the Inflammatory Profile of Patients With X-linked Hypophosphatemic Rickets FLAM-XLH Expression of inflammatory markers (Il6, Il8, Il1β, CXCL1, CCL2, CXCR3, Il1R, Il6R) - X-Linked Hypophosphatemic Rickets | Unknown | Hospices Civils de Lyon | 20 | 2024-04-01 | 2024-03-06 | |
| Study Evaluating Patients With Cystinuria and Efficacy and Safety Exploratory Study in the Youngest Children ADV7103, Placebo - Cystinuria | Phase 2 / Phase 3 | Withdrawn | Advicenne Pharma | 2024-03-01 | 2026-01-08 | |
| Transient Pseudohypoaldosteronism Affecting Children With Urinary Tract Malformation Pseudohypoaldosteronism | Unknown | University Hospital, Strasbourg, France | 50 | 2024-01-31 | 2025-04-01 | |
| Extension Study in Primary Distal Renal Tubular Acidosis ADV7103 - Acidosis, Renal Tubular | Phase 3 | Withdrawn | Advicenne Pharma | 2023-12-20 | 2026-02-09 | |
| Long Term Clinical Efficacy of Sodium-glucose Cotransporter-2 (SGLT-2) Inhibitor in Cystinurics Dapagliflozin - Cystinuria | Phase 2 | Withdrawn | University of California, San Francisco | 2023-09-01 | 2025-08-29 | |
| The Necessity of a Second Transurethral Resection in High-risk Non-muscle-invasive Bladder Cancer Patients With Negative Urine Biomarker After Initial Transurethral Resection Urine biomarker -Guided without reTURBT - Non Muscle Invasive Bladder Cancer | Not applicable | Recruiting | The First Affiliated Hospital with Nanjing Medical University | 428 | 2023-07-01 | 2024-03-01 |
| Association of Renal-tubular Acidosis in Children With Cow Milk Protein Allergy investigations - Cow's Milk Protein Allergy, Rta | Completed | Sohag University | 120 | 2023-06-03 | 2024-07-10 | |
| Observational Follow-up Study of Haplo-identical Transplants in Fanconi Disease Blood sampling - Fanconi Syndrome | Not yet recruiting | Assistance Publique - Hôpitaux de Paris | 18 | 2023-06-01 | 2023-06-15 | |
| Anergia-anhedonia by Lithium-induced Phosphorus Diabetes Mood Disorders | Unknown | University Hospital, Strasbourg, France | 60 | 2023-05-01 | 2023-11-01 |
Showing 20 of 125. Sign in to see all of them.
Familial Hypophosphatemic Rickets (49) · Cystinuria (21) · Fanconi Syndrome (15) · Dent Disease (12) · Pseudohypoaldosteronism (12) · Hypophosphatemia (10) · Acidosis, Renal Tubular (9) · Adenine phosphoribosyltransferase deficiency (7) · Cystinosis (7) · Hyperoxaluria, Primary (7) · Gitelman Syndrome (6) · Hypophosphatemia, Familial (6) · Kidney Calculi (6) · Oculocerebrorenal Syndrome (6) · Rare Diseases (6)
Female Urogenital Diseases (125) · Female Urogenital Diseases and Pregnancy Complications (125) · Male Urogenital Diseases (125) · Urologic Diseases (125) · Urogenital Diseases (124) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (123) · Kidney Diseases (123) · Genetic Diseases, Inborn (122) · Nutritional and Metabolic Diseases (87) · Metabolic Diseases (86) · Metabolism, Inborn Errors (68) · Musculoskeletal Diseases (56) · Calcium Metabolism Disorders (55) · Metal Metabolism, Inborn Errors (55)
burosumab (20) · Potassium Citrate (4) · Blood Specimen Collection (3) · Acetazolamide (2) · Calcitriol (2) · Cinacalcet (2) · Health Records, Personal (2) · Hydrochlorothiazide (2) · Multicenter Studies as Topic (2) · Physical Examination (2) · Sodium Bicarbonate (2) · Tiopronin (2) · dapagliflozin (2) · potassium bicarbonate (2) · 1,25-dihydroxyvitamin D (1)
Kyowa Kirin Co., Ltd. (10) · Assistance Publique - Hôpitaux de Paris (9) · Mayo Clinic (8) · Kyowa Kirin, Inc. (6) · Kyowa Kirin Pharmaceutical Development Ltd (5) · NYU Langone Health (5) · Advicenne Pharma (4) · Rocket Pharmaceuticals Inc. (4) · Children's Mercy Hospital Kansas City (3) · Hospices Civils de Lyon (3) · Yale University (3) · Bicetre Hospital (2) · National Center for Research Resources (NCRR) (2) · Novartis Pharmaceuticals (2) · The First Affiliated Hospital with Nanjing Medical University (2)
United States (60) · France (25) · United Kingdom (13) · Canada (12) · Germany (8) · China (7) · Italy (7) · Japan (7) · Spain (7) · Belgium (5) · Netherlands (5) · Israel (4) · South Korea (4) · Austria (3) · Denmark (3)
David Goldfarb, MD (4) · John C Lieske, M.D. (3) · Amy Zhang, PhD (2) · David S Goldfarb, MD (2) · Agnieszka Czechowicz, MD (1) · Andre Ulmann, M.D., Ph.D. (1) · Andrew J Lipton, M.D. (1) · Andrew M South, MD MS (1) · Anne Blanchard, MD, PhD (1) · Ari Auron, MD (1) · Blanchard Anne, MD,PhD (1) · Bruce S. Keenan (1)
PMID 39151033, PMID 32721016, PMID 40962182, PMID 25919461, PMID 36854566, PMID 18976849, PMID 20716238, PMID 21161651, PMID 21183586, PMID 21419606, PMID 21514598, PMID 21926392, PMID 21926394, PMID 21926395, PMID 21926396, PMID 22177992, PMID 22184204, PMID 22205430, PMID 22276227, PMID 22328589, PMID 22499950, PMID 23040496, PMID 23477994, PMID 23852419, PMID 24569459, PMID 24577564, PMID 25029424, PMID 25365230, PMID 25717071, PMID 25888397, PMID 26073451, PMID 26494722, PMID 27070726, PMID 28822957, PMID 29791829, PMID 29947083, PMID 30638856, PMID 31104833, PMID 31165191, PMID 31315600, PMID 31369102, PMID 32601114, PMID 33107592, PMID 33484279, PMID 33528045, PMID 34548383, PMID 34636899, PMID 35142618, PMID 35533340, PMID 35775373
U54DK083908 (5), 2014 (1), 2018 (1), P20DK100863 (1), P50AR054086 (1), P50DK083007 (1), R01DE030872 (1), R21AR061818 (1), U54RR019480 (1)